Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The IGBallon (R) - for Use in the Treatment of Obesity

NCT: NCT07647991 · COMPLETED

NCT IDNCT07647991
StatusCOMPLETED
Start Date2024-03-01
Completion2024-07-15
SponsorMedical University of Vienna (OTHER)
First posted
Last updated

Brief Summary

This study is a prospective, non-randomized, open-label, single-center study. The aim of this study is to assess the safety of the IGballoon in the human body. The effectiveness of the IGBalloon in relation to weight loss behaviour of the human body will also be investigated. This study will involve 20 participants who will be divided into two groups: 1. Monitoring group with 5 participants who swallow an IGBalloon. After four weeks, safety will be tested. Up to four additional IGBalloons may be ingested, if necessary, over the following eight weeks. 2. Treatment group of 15 participants receiving up to 5 IGBalloons over a period of 8 weeks as required. This group will be evaluated for efficiency of the IGBalloon. Various examinations, such as clinical examinations, blood tests, and gastroscopies will be carried out at certain follow-up points. Patients also receive dietary support for the entire duration of the study.

Frequently Asked Questions

What is The IGBallon (R) - for Use in the Treatment of Obesity?

The IGBallon (R) - for Use in the Treatment of Obesity is a clinical trial registered under NCT07647991. Current status: COMPLETED.

What is the status of NCT07647991?

The current status of NCT07647991 (The IGBallon (R) - for Use in the Treatment of Obesity) is: COMPLETED.

When did The IGBallon (R) - for Use in the Treatment of Obesity start?

The IGBallon (R) - for Use in the Treatment of Obesity started on 2024-03-01.

Related Devices

K220371Nitrile Two Toned Blue/Green, Powder-Free, Non-sterile, Ambidextrous, Beaded Cuff, Medical Grade Exam Gloves, Tested for Use with the Opioids Fentanyl citrate, Heroin, and both Opioids in simulated Gastric Acid (Vomit)Summit Glove, Inc. K220375Intercept Free, Nitrile Two Toned White/Green, Textured Fingertips, Powder-Free, Non-sterile, Ambidextrous, Beaded Cuff, Medical Examination Gloves, Tested for Use with Opioids Fentanyl citrate, Heroin, and both Opioids in simulated Gastric Acid (Vomit)Summit Glove, Inc. K223752Black Non Sterile Powder Free Nitrile Examination Gloves, Tested for Use with Chemotherapy Drugs, with Chloroquine, Cyclosporin A, Retrovir, Gastric Acid and FentanylCentral Medicare Sdn Bhd K230681Blue Non Sterile Powder Free Nitrile Examination Gloves Tested for Use with Chemotherapy Drugs, with Gastric Acid and FentanylCentral Medicare Sdn Bhd

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑